SCHEMBL9764073

SCHEMBL9764073

N#Cc1cccnc1OC(=O)c1ccccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
PKM P14618 2/20 0.46
MITF O75030 1/20 0.46
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 3/20 0.45
KMT2A Q03164 5/20 0.44
MAPT P10636 4/20 0.44
MEN1 O00255 3/20 0.44
LMNA P02545 2/20 0.44
POLB P06746 2/20 0.44
GAA P10253 1/20 0.43
HPGD P15428 3/20 0.41
TP53 P04637 1/20 0.41
ESR1 P03372 2/20 0.41
ESR2 Q92731 2/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27712540 0.80 LMNA (0.48) NPC1RAB9ASMN1; SMN2PKMMITF
SCHEMBL29145521 0.75 KDM4E (0.45) RAB9ASMN1; SMN2ALDH1A1KDM4EGAA
SCHEMBL1291219 0.74 ELANE (0.44) ALDH1A1KDM4ELMNAHPGDESR1
SCHEMBL29145515 0.74 PLCG1 (0.44) SMN1; SMN2ALDH1A1KDM4EGAAHPGD
SCHEMBL9671426 0.72 KMT2A (0.43) NPC1RAB9ASMN1; SMN2PKMMITF
SCHEMBL28896336 0.71 KDM4E (0.43) SMN1; SMN2ALDH1A1KDM4EGAAHPGD
SCHEMBL27712539 0.69 LMNA (0.51) NPC1RAB9ASMN1; SMN2PKMMITF
SCHEMBL29145518 0.69 SSTR4 (0.46) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL15303617 0.68 KDM4E (0.50) ALDH1A1KDM4EHPGD
SCHEMBL3432978 0.67 NPC1 (0.43) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5047521-A Anticarcinogenic agents OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-09-10 US disclosed